Sandostatin is also known as SANDOSTATIN LAR, Octreotide Acetate Injection, Octreotide Acetate Injection, and Octreotide. Many patients who are not familiar with drugs are unfamiliar with Sandostatin. This article will mainly explain the relevant information of Sandostatin to help patients further understand Sandostatin.
What is Sandostatin?
What disease does Sandostatin treat?
Sandostatin is mainly used in the treatment of acromegaly in clinical practice. The indication population is patients with acromegaly who have insufficient response to surgery and/or radiotherapy, or patients who cannot choose surgery and/or long-term maintenance treatment. If used to treat acromegaly, the main treatment goal of the patient is to reduce the levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) to normal levels.
In addition to the treatment of acromegaly, Sandostatin can also be used to treat carcinoid and VIPoma. It can be used for the long-term treatment of severe diarrhea and flushing associated with metastatic carcinoid, and the long-term treatment of large amounts of watery diarrhea associated with VIPoma.
After understanding the drug indications of Sandostatin, the following will describe the mechanism of action of Sandostatin:
The mechanism of action of Sandostatin
Treatment of acromegaly
Sandostatin mainly regulates the secretion of various hormones and physiologically active substances in the body by simulating physiological mechanisms. When used to treat acromegaly, Sandostatin inhibits the secretion of growth hormone to reduce the effect of growth hormone in the body, relieves the patient's symptoms, reduces the excessive growth of bones and soft tissues, and improves the patient's quality of life.
Treatment of carcinoid
Sandostatin can inhibit the secretion of various hormones in the body. When the secretion of hormones is reduced, the growth of tumors can be delayed. After injection of Sandostatin, the symptoms of various carcinoids such as paroxysmal right upper abdominal pain and fever can be effectively relieved.
Treatment of VIPoma
When used to treat VIPoma, octreotide can bind to VIP receptors to inhibit the effect of VIP, reduce its secretion, and control the symptoms caused by VIPoma, such as diarrhea, tachycardia, and hypotension. Octreotide can also slow the growth rate of tumors and has a certain effect in the treatment of VIPoma.
Sandostatin has a good therapeutic effect. Patients in need can buy Sandostatin in hospitals or pharmacies, but it should be noted that Sandostatin requires a prescription. Before buying Sandostatin, you should go to the hospital to get a prescription. Sandostatin is a prescription drug, which means that its use requires professional guidance and monitoring by a doctor. Because this drug has potential risks of abuse and dependence, in order to reduce the risk of abuse and dependence, doctors must conduct strict supervision and control.
The prescription system can prevent patients from self-diagnosis and self-treatment. Doctors make accurate diagnoses and prescribe appropriate prescription drugs based on the patient's condition and medical history, which helps ensure that patients receive the right treatment and avoid errors and potential risks caused by self-diagnosis and self-treatment.
